News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Ashland reported Q3 sales up 7% to $497M and reaffirmed its full-year sales and Adjusted EBITDA guidance.
  • Methanex posted Q2 net income of $198M and $577M adjusted EBITDA on record North American production, while repaying debt and returning cash.
  • Sound Financial posted Q2 net income of $2.5M, declared a $0.21 quarterly dividend and strengthened its loan portfolio metrics.
  • Kentucky First Federal declared a $0.05 quarterly dividend, noting its majority shareholder waived up to $0.40 per share in dividends.
  • Gran Tierra and Health Catalyst scheduled Q2 results and conference calls for early August.
  • Analyst pitches target buying LATAM on a tactical Q2 dip and going long COMPASS Pathways on clinical momentum and regulatory tailwinds.
  • Seer stockholders re-elected all seven director nominees, preserving board continuity as the company scales proteomics commercialization.

Latest Articles

Iron Dome Acquisition I Corp. raises $150 million in IPO of units

Iron Dome Acquisition I Corp. raises $150 million in IPO of units

Iron Dome Acquisition I Corp. completed a $150 million initial public offering by selling 15 million units at $10 each. The special purpose acquisition company began trading its units on the Nasdaq Global Market on May 15, 2026, and expects its Class A shares and warrants to trade separately under the ticker symbols IDAC and IDACW once separation o…

Piper Sandler Moves Deckers to Neutral, Sees Q4 Earnings Beat Potential

Piper Sandler Moves Deckers to Neutral, Sees Q4 Earnings Beat Potential

Piper Sandler upgraded Deckers Outdoor Corporation to Neutral from Underweight after a recent decline in the share price improved the balance of risk and reward ahead of the company’s fiscal fourth-quarter results due May 21. The firm raised its price target to $100 and projects an earnings and revenue beat for the quarter driven by direct-to-consu…

Upstart Executive Sells Shares Amid Mixed Financial Signals

Upstart Executive Sells Shares Amid Mixed Financial Signals

Sanjay Datta, President of Capital & Enterprise at Upstart Holdings, Inc., recently sold a total of 1,817 shares of common stock valued at $53,707. The transaction was reportedly to cover tax withholding related to the vesting of restricted stock units (RSUs). Despite this insider selling activity, the company's recent financial disclosures present…

Global Bond Selloff Triggers Market Retreat Amid Rising Inflation Fears

Global Bond Selloff Triggers Market Retreat Amid Rising Inflation Fears

Equities experienced a broad retreat on Monday as an intensifying global bond rout pushed yields to historic levels. The spike in yields has clouded the economic outlook, creating headwinds for stock markets and dampening enthusiasm for the ongoing artificial intelligence rally ahead of critical earnings reports from major players like Nvidia. As i…

Moderna Executive Transactions and Company Developments Under Review

Moderna Executive Transactions and Company Developments Under Review

The report details a recent transaction by Moderna President Stephen Hoge, who sold shares following an earlier acquisition, all conducted under pre-scheduled trading plans. Furthermore, it outlines several material developments for the company, including amendments to its bylaws concerning legal forums and progress in early-stage vaccine research.

RGA Executive Sells Stock Amid Strong Q1 Performance and Market Divergence

RGA Executive Sells Stock Amid Strong Q1 Performance and Market Divergence

Ronald Herrmann, an Executive Vice President at Reinsurance Group of America Inc. (NYSE:RGA), sold a total value of approximately $1,474,041 worth of common stock in May 2026. This sale occurred against a backdrop of RGA's impressive first quarter financial results, where the company reported earnings per share (EPS) of $6.97 and revenue of $6.49 b…

Marqeta's Insider Activity and Q1 Performance Update

Marqeta's Insider Activity and Q1 Performance Update

The article details a notable sale of Marqeta, Inc. stock by its Chief Administrative Officer. This transaction is presented against the backdrop of the company's recently reported Q1 2026 earnings, where it achieved GAAP profitability and exceeded revenue forecasts. Furthermore, the announcement of a new CTO strengthens the company's technological…

Antalpha Announces Strategic Expansion Into AI Infrastructure

Antalpha Announces Strategic Expansion Into AI Infrastructure

Antalpha, a fintech company listed on NASDAQ, announced a strategic expansion into AI infrastructure and intelligent routing systems. The company unveiled its proprietary Model Context Protocol (MCP) framework along with the launch of "Nina," an early-stage AI-driven agentic interface, signaling a long-term shift toward foundational AI infrastructu…

U-BX Technology Ltd. Announces Effective Date of Reverse Stock Split

U-BX Technology Ltd. Announces Effective Date of Reverse Stock Split

U-BX Technology Ltd., a NASDAQ-listed insurance technology provider, announced it will implement a 1-for-25 reverse stock split effective May 22, 2026. The move consolidates the company’s outstanding shares, reducing class A shares from approximately 37.79 million to 1.51 million and class B shares from 7.66 million to 0.31 million. This action fol…

Cullinan Therapeutics to Present Initial Clinical Data for CLN-978 in Treatment-Refractory Rheumatoid Arthritis and Systemic Lupus Erythematosus at EULAR 2026 Congress

Cullinan Therapeutics to Present Initial Clinical Data for CLN-978 in Treatment-Refractory Rheumatoid Arthritis and Systemic Lupus Erythematosus at EULAR 2026 Congress

Cullinan Therapeutics, a clinical-stage biopharmaceutical company, will present initial clinical data from two ongoing Phase 1 studies of CLN-978, a novel bispecific CD19xCD3 T cell engager, at the EULAR 2026 Congress. The data from treatment-refractory rheumatoid arthritis and systemic lupus erythematosus patients show a favorable safety profile, …

Executive Sale and Strong Earnings Signal for Miami International Holdings

Executive Sale and Strong Earnings Signal for Miami International Holdings

Miami International Holdings' Executive Vice President and CFO, Lance Emmons, completed a sale of common stock valued at $1.97 million on May 15, 2026. This transaction was executed through a pre-arranged Rule 10b5-1 trading plan. The report details this insider activity alongside the company's recent financial performance, noting that Miami Intern…